Skip to content
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
Menu
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
accuray-logo-20
  • Who We Are
    • –
  • Resources
    • –
  • Products
    • –
  • Services
    • –
Menu
  • Who We Are
    • –
  • Resources
    • –
  • Products
    • –
  • Services
    • –
Search
Close
accuray-logo-20.svg

Indication: Malignant

A prospective evaluation of the combined helical tomotherapy and chemotherapy in pediatric patients with unresectable rhabdomyosarcoma of the temporal bone

Zhang X, Ma K, Wang J, Wu W, Ma L, Huang D | Cell Biochem Biophys | 2014

Clinical implementation of radiosurgery using the Helical TomoTherapy unit

Saw CB, Gillette C, Peters CA, Koutcher L | Med Dosim | 2018

Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm

Koide Y, Tomita N, Adachi S, Tanaka H, Tachibana H, Kodaira T | Nagoya J Med Sci | 2019

Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy

Arpa D, Parisi E, Ghigi G, Savini A, Colangione SP, Tontini L, Pieri M, Foca F, Polico R, Tesei A, Sarnelli A, Romeo A | Sci Rep | 2020

Comparison of Absolute Dose Achievable Between Helical Tomotherapy and RapidArc in Total Dura Mater Irradiation for Child Cancer

Wenzhao Sun, Jun Zhang, Yixuan Wang, Meining Chen, Jianli Wang, Li Chen, Lixia Lu, Xiaowu Deng. | Technol Cancer Res Treat | 2022

Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis

Pinzi V, Orsi C, Marchetti M, Milanesi IM, Bianchi LC, DiMeco F, Cuccarini V, Farinotti M, Ferroli P, Finocchiaro G, Franzini A, Fumagalli M, Silvani A, Fariselli L | Neurol Sci | 2015

CyberKnife Stereotactic Radiosurgery for Atypical and Malignant Meningiomas

Zhang M, Ho AL, D’Astous M, Pendharkar AV, Choi CY, Thompson PA, Tayag AT, Soltys SG, Gibbs IC, Chang SD | World Neurosurg | 2016

Long-Term Outcomes Following Conventionally Fractionated Stereotactic Boost for High-Grade Gliomas in Close Proximity to Critical Organs at Risk

Repka MC, Lei S, Campbell L, Suy S, Voyadzis JM, Kalhorn C, McGrail K, Jean W, Subramaniam DS, Lischalk JW, Collins SP, Collins BT | Front Oncol | 2018

CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis

De Maria L, Terzi di Bergamo L, Conti A, Hayashi K, Pinzi V, Murai T, Lanciano R, Burneikiene S, Buglione di Monale M, Magrini SM, Fontanella MM | Front Oncol | 2021

Is the CyberKnife © radiosurgery system effective and safe for patients? An umbrella review of the evidence

Yifan Cheng, Yifei Lin, Youlin Long, Liang Du, Rui Chen, Tengyue Hu, Qiong Guo, Ga Liao, Jin Huang | Future Ocol | 2022

Treatment of Residual, Recurrent, or Metastatic Intracranial Hemangiopericytomas With Stereotactic Radiotherapy Using CyberKnife

Huang L, Bai J, Zhang Y, Cui Z, Zhang Z, Li J, Wang J, Yu X, Ling Z, Qu B, Pan L | Front Oncol | 2021

Image-Guided Robotic Radiosurgery for the Management of Spinal Ependymomas

Ehret F, Kufeld M, Fürweger C, Haidenberger A, Windisch P, Senger C, Kord M, Träger M, Kaul D, Schichor C, Tonn JC, Muacevic A | Front Oncol | 2021

The Stanford stereotactic radiosurgery experience on 7000 patients over 2 decades (1999-2018): looking far beyond the scalpel

Fatima N, Meola A, Ding VY, Pollom E, Soltys SG, Chuang CF, Shahsavari N, Hancock SL, Gibbs IC, Adler JR, Chang SD.J | Neurosurg | 2021

PO-1158: Re-irradiation with Stereotactic Radiotherapy for Recurrent High Grade Glial Tumors

Ela Delikgoz Soykut, Eylem Odabasi, Nilgun Sahin | ESTRO | 2022

Adaptive Planning Using PreciseART for Glioblastoma Patient Wearing Tumor Treating Fields Device

Y Qin, R Tobias, R Foster, M Pankuch | AAPM | 2022

Dosimetric Evaluation of the Treatment Goals Effectiveness of VMAT / Cyber Knife Versus IMPT When LET / Variable RBE Are Taken Into Consideration for Brain Tumors

H Kamal Sayed, Q Xu, J Fan | AAPM | 2022

Facebook-f Linkedin Twitter Youtube
  • CyberKnife®
  • Radixact®
  • TomoTherapy®
  • Accuray Precision® Treatment Planning
  • iDMS® Data Management
  • CyberKnife®
  • Radixact®
  • TomoTherapy®
  • Accuray Precision® Treatment Planning
  • iDMS® Data Management
  • Careers
  • Services
  • Patients
  • Investors
  • Contact Us
  • Careers
  • Services
  • Patients
  • Investors
  • Contact Us
  • Conflict Minerals Policy Statement
  • Privacy Policy
  • Terms of Use
  • EthicsPoint Hotline
  • Cookie Use Notice
  • India eWaste Management Program
  • Trademarks
  • Conflict Minerals Policy Statement
  • Privacy Policy
  • Terms of Use
  • EthicsPoint Hotline
  • Cookie Use Notice
  • India eWaste Management Program
  • Trademarks

Safety Statement for Radiation Treatment:
Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death. Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient’s general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.

© 2023 Accuray Incorporated, All Rights Reserved. The stylized Accuray logo, CyberKnife, VSI, M6, TomoTherapy, H Series, Tomo, TomoH, TomoHD, TomoHDA, TomoEDGE, TomoHelical, TomoDirect, Hi·Art, PlanTouch, PreciseART, PreciseRTX, Radixact, Accuray Precision, iDMS, Iris, Xchange, RoboCouch, InCise, MultiPlan, Xsight, Synchrony, InTempo, TxView, PlanTouch, QuickPlan, TomoHelical, TomoDirect, TomoEDGE, CTrue, ClearRT, VoLO, Planned Adaptive, TQA, TomoLink, TomoPortal, OIS Connect and AERO are trademarks or registered trademarks of Accuray Incorporated, in the United States and other countries and may not be used or distributed without written authorization from Accuray Incorporated. Use of Accuray Incorporated’s trademarks requires written authorization from Accuray Incorporated.

  • Home
  • AI Real-time Tracking
  • Hypofractionation Trend
  • 20+ Years of Evidence
  • Adaptation in Action
  • CyberKnife® S7™
  • Radixact®
  • Home
  • AI Real-time Tracking
  • Hypofractionation Trend
  • 20+ Years of Evidence
  • Adaptation in Action
  • CyberKnife® S7™
  • Radixact®
Who we are
  • Company
  • Leadership
  • Careers
  • Locations
  • News
  • Media
  • Events
  • Partners
  • Investors
Resources

  • 20+ Years of Evidence
  • Blog
  • Innovation
  • Case Studies
  • Patients
  • Product Resources
  • Veterinary Oncology
  • Cybersecurity

Treatment Centers

Find a Facility Near You

Products
  • Overview
  • Entrega do Tratmento
  • Resources
  • Overview
  • Entrega do Tratmento
  • Resources
  • Overview
  • Entrega do Tratamento
  • Resources
  • Accuray Precision® Treatment Planning
  • PreciseART®
  • PreciseRTX®
  • iDMS® Data Management
  • Synchrony®
  • RayStation®
  • RayCare®
Services
  • Service Overview
  • Site Planning and Installation
  • Training
  • CyberKnife®
  • Radixact®
  • Technology Upgrades
  • Service Support
  • Customer Resources
  • AERO™ Community
  • Service Requests
  • Contact Us
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
  • English

Unmatched service to protect uptime and maximize ROI

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

  • Service Overview
  • Site Planning And Installation
  • Training
  • CyberKnife®
  • Radixact®
  • Alliance Advances
  • Service Support
  • Customer Resources
  • Contact
  • Overview
  • Treatment Delivery
  • Resources
  • Overview
  • Treatment Delivery
  • Resources
  • Overview
  • Treatment Delivery
  • Resources
  • Accuray Precision® Treatment Planning
  • PreciseART®
  • PreciseRTX®
  • iDMS® Data Management
  • Synchrony®
  • RayStation®
  • RayCare®

Redefining the future of cancer care

Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.

Treatment Centers

Find a Facility Near You
  • 20+ Years of Evidence
  • Blog
  • Innovation
  • Case Studies
  • Patients
  • Product Resources
  • Veterinary Oncology
  • Cybersecurity

Accuray treatment options

The following pages explore some of the many ways clinicians around the globe use Accuray technologies to deliver unique and effective treatments for a wide range of clinical indications.

Treatment Centers

Find a Facility Near You

Breast

  • IMRT with TomoHelical™
  • 3DCRT with TomoDirect™

Intracranial

  • SRS with CyberKnife ®

Prostate

  • SBRT with CyberKnife®

Lung

  • SBRT with CyberKnife®

Head and Neck

  • IMRT with TomoHelical™

Veterinary

  • Veterinary Oncology with
    CyberKnife® & TomoTherapy®

About Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.

  • Company
  • Leadership
  • Careers
  • Locations
  • News
  • Media
  • Corporate Citizenship
  • Events
  • Partners
  • Investors